Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects

Clinical trial NCT00707746 · COMPLETED

Trial details

NCT number: NCT00707746
Sponsor: Kastle Therapeutics, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metabolic Diseases Hyperlipidemias Metabolic Disorder Hypercholesterolemia Dyslipidemias Lipid Metabolism Disorders

Start date: 2008-10-01
Primary completion: 2010-08-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.